A twice-daily dose of
Celebrex over a period of nine months reduced the incidence of nonmelanoma skin cancer by almost 60 percent, according a new study. Read on..
SID: COX-2 Inhibitors May Cut Skin Cancer Rate
Follow the story of Tracey who's insurer would not pay for her
Celebrex prescription. Read on...
Who's the Doctor?